Myocardial Ablation of G Protein–Coupled Receptor Kinase 2 (GRK2) Decreases Ischemia/Reperfusion Injury Through an Anti-Intrinsic Apoptotic Pathway

PLoS ONE - United States
doi 10.1371/journal.pone.0066234
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Ilexsaponin a Attenuates Ischemia-Reperfusion-Induced Myocardial Injury Through Anti-Apoptotic Pathway

PLoS ONE
Multidisciplinary
2017English

Neuroprotection of Osthole Against Cerebral Ischemia/Reperfusion Injury Through an Anti-Apoptotic Pathway in Rats

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2016English

Feedback Inhibition of G Protein-Coupled Receptor Kinase 2 (GRK2) Activity by Extracellular Signal-Regulated Kinases

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

G Protein-Coupled Receptor Kinase 2 Ablation in Cardiac Myocytes Before or After Myocardial Infarction Prevents Heart Failure

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2008English

Heterotrimeric G Protein 1 2 Subunits Change Orientation Upon Complex Formation With G Protein-Coupled Receptor Kinase 2 (GRK2) on a Model Membrane

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Degradation of the G Protein-Coupled Receptor Kinase 2 by the Proteasome Pathway

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Neuroprotective Capabilities of Tanshinone IIA Against Cerebral Ischemia/Reperfusion Injury via Anti-Apoptotic Pathway in Rats

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2012English

G Protein-Coupled Receptor Kinase 2 Promotes Cardiac Hypertrophy

PLoS ONE
Multidisciplinary
2017English

The Protein Kinase 2 Inhibitor Tetrabromobenzotriazole Protects Against Renal Ischemia Reperfusion Injury

Scientific Reports
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy